DelistingApr 21, 2026, 08:06 AM
ENDRA Life Sciences non-compliant with Nasdaq equity rule; $2.26M equity
AI Summary
ENDRA Life Sciences Inc. announced it is again non-compliant with Nasdaq's minimum stockholders' equity requirement of $2,500,000. The company received a letter on April 20, 2026, after its Annual Report on Form 10-K for December 31, 2025, showed stockholders' equity of $2,260,120. This follows a previous period of non-compliance in 2025, which the company had resolved in November 2025.
Key Highlights
- Received Nasdaq non-compliance notice on April 20, 2026.
- Stockholders' equity was $2,260,120 as of December 31, 2025.
- Nasdaq minimum stockholders' equity requirement is $2,500,000.
- Company had previously regained compliance in November 2025.